A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications

Direct targeting of β ‐catenin in the Wnt signaling pathway: Current progress and perspectives

(2021) Zhen Wang et al.   MEDICINAL RESEARCH REVIEWS

Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2

(2020) Ken Morita et al.   CELL

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

(2020) Ugur Sahin et al.   NATURE

Novel treatment strategies for early-stage lung cancer: the oncologist’s perspective

(2020) Alice Indini et al.   Journal of Thoracic Disease

A Novel Method to Identify Autoantibodies against Putative Target Proteins in Serum from beta-Thalassemia Major: A Pilot Study

(2020) Afshan Sumera et al.   Biomedicines

Detection of putative autoantibodies in systemic lupus erythematous using a novel native-conformation protein microarray platform

(2020) Anselm Mak et al.   LUPUS

Multimodel inference for biomarker development: an application to schizophrenia

(2019) Jason D. Cooper et al.   Translational Psychiatry

Benchmark for filter methods for feature selection in high-dimensional classification data

(2019) Andrea Bommert et al.   COMPUTATIONAL STATISTICS & DATA ANALYSIS

PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells

(2018) Otto Kauko et al.   Science Translational Medicine

A diagnostic autoantibody signature for primary cutaneous melanoma

(2018) Pauline Zaenker et al.   Oncotarget

B cells and antibody production in melanoma

(2018) Jessica Da Gama Duarte et al.   MAMMALIAN GENOME

ranger: A Fast Implementation of Random Forests for High Dimensional Data in C++ and R

(2017) Marvin N. Wright et al.   Journal of Statistical Software

A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions

(2017) Marc Damelin et al.   Science Translational Medicine

MAEL contributes to gastric cancer progression by promoting ILKAP degradation

(2017) Xing Zhang et al.   Oncotarget

Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer Patients

(2016) P. Zaenker et al.   AUTOIMMUNITY REVIEWS

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

(2016) Peter Goldstraw et al.   Journal of Thoracic Oncology

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

(2016) Uraujh Yousaf-Khan et al.   THORAX

Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway

(2016) Ae Lee Jeong et al.   Scientific Reports

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

(2015) Elin S. Gray et al.   Oncotarget

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers

(2014) Nanda Horeweg et al.   LANCET ONCOLOGY

Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer

(2014) JI-HEE KIM et al.   ONCOLOGY REPORTS

Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers

(2013) S. Rousseaux et al.   Science Translational Medicine

A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

(2012) Johannes R Kratz et al.   LANCET

Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors

(2012) A. Gurney et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Optimally splitting cases for training and testing high dimensional classifiers

(2011) Kevin K Dobbin et al.   BMC Medical Genomics

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation

(2011) Thomas Karn et al.   EUROPEAN JOURNAL OF CANCER

Proteomic analysis of resectable non-small cell lung cancer: post-resection serum samples may be useful in identifying potential markers

(2011) Sridhar Rathinam et al.   Interactive Cardiovascular and Thoracic Surgery

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?

(2010) J. Subramanian et al.   JNCI-Journal of the National Cancer Institute

Serine/threonine phosphatases in the DNA damage response and cancer

(2010) A Peng et al.   ONCOGENE

Comprehensive Profiling of the Cell Surface Proteome of Sy5Y Neuroblastoma Cells Yields a Subset of Proteins Associated with Tumor Differentiation

(2009) Jacob Garcia et al.   JOURNAL OF PROTEOME RESEARCH

Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays

(2008) Sacha Gnjatic et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Next-generation high-density self-assembling functional protein arrays

(2008) Niroshan Ramachandran et al.   NATURE METHODS